Ocugen (OCGN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Ocugen (OCGN) is Neutral.

The composite score behind that read is -0.18, weighing +0.36 of bullish evidence against -0.27 bearish.

Ocugen last closed at $1.04, +1.96% on the session.

Against the IVW growth benchmark the position is +1.04% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

Ocugen has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Ocugen in the 99th percentile on return on equity, where 100 is best.

Ocugen is classified under Health Care / Biotechnology, with a market capitalisation of $345.89M.

StockMap tracks Ocugen as the 188th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Ocugen ranks 144th of 344 in the group, against a group median of -0.21.